Literature DB >> 11389542

Significance of protein kinase CK2 nuclear signaling in neoplasia.

K Ahmed1, A T Davis, H Wang, R A Faust, S Yu, S Tawfic.   

Abstract

Many stimuli play a role in influencing the structure and function of chromatin and nuclear matrix through post-translational modifications of the component proteins in these dynamic structures. We propose that the protein serine/threonine kinase CK2 (formerly casein kinase II) is one such agent that is involved in signal transduction in the nuclear matrix and chromatin in response to a variety of stimuli. Protein kinase CK2 appears to undergo rapid modulations in its association with nuclear matrix and nucleosomes in response to mitogenic signals and is involved in the phosphorylation of a variety of intrinsic proteins in these structures depending on the state of genomic activity. In addition, its association or loss from the nuclear matrix may also influence the apoptotic activity in the cell. CK2 has been found to be dysregulated in virtually all the neoplasias examined and nuclear association appears to be an important facet of its expression in tumor cells. We hypothesize that CK2 provides a functional paradigm linking the nuclear matrix and chromatin structures. Identification of precise loci of action of CK2 in these structures and how they influence the morphological appearance of the nucleus under normal and abnormal growth conditions would be an important future direction of investigation. J. Cell. Biochem. Suppl. 35:130-135, 2000. Published 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11389542     DOI: 10.1002/1097-4644(2000)79:35+<130::aid-jcb1136>3.0.co;2-n

Source DB:  PubMed          Journal:  J Cell Biochem Suppl        ISSN: 0733-1959


  24 in total

1.  Consequences of CK2 signaling to the nuclear matrix.

Authors:  S Yu; H Wang; A Davis; K Ahmed
Journal:  Mol Cell Biochem       Date:  2001-11       Impact factor: 3.396

Review 2.  Emergence of protein kinase CK2 as a key target in cancer therapy.

Authors:  Janeen H Trembley; Zhong Chen; Gretchen Unger; Joel Slaton; Betsy T Kren; Carter Van Waes; Khalil Ahmed
Journal:  Biofactors       Date:  2010 May-Jun       Impact factor: 6.113

3.  CK2 interacting proteins: emerging paradigms for CK2 regulation?

Authors:  Mary Ellen K Olsten; Jane E Weber; David W Litchfield
Journal:  Mol Cell Biochem       Date:  2005-06       Impact factor: 3.396

4.  Downregulation of CK2 induces apoptosis in cancer cells--a potential approach to cancer therapy.

Authors:  Guixia Wang; Gretchen Unger; Kashif A Ahmad; Joel W Slaton; Khalil Ahmed
Journal:  Mol Cell Biochem       Date:  2005-06       Impact factor: 3.396

Review 5.  Protein kinase CK2--a key suppressor of apoptosis.

Authors:  Kashif A Ahmad; Guixia Wang; Gretchen Unger; Joel Slaton; Khalil Ahmed
Journal:  Adv Enzyme Regul       Date:  2008-04-30

6.  CK2 phosphorylation of SAG at Thr10 regulates SAG stability, but not its E3 ligase activity.

Authors:  Hongbin He; Mingjia Tan; Deepika Pamarthy; Guixia Wang; Khalil Ahmed; Yi Sun
Journal:  Mol Cell Biochem       Date:  2006-07-28       Impact factor: 3.396

7.  A role for CK2alpha/beta in Xenopus early embryonic development.

Authors:  Isabel Dominguez; Junko Mizuno; Hao Wu; Gregory A Imbrie; Karen Symes; David C Seldin
Journal:  Mol Cell Biochem       Date:  2005-06       Impact factor: 3.396

8.  Response of cancer cells to molecular interruption of the CK2 signal.

Authors:  H Wang; A Davis; S Yu; K Ahmed
Journal:  Mol Cell Biochem       Date:  2001-11       Impact factor: 3.396

9.  Structural and functional insights into the regulation mechanism of CK2 by IP6 and the intrinsically disordered protein Nopp140.

Authors:  Won-Kyu Lee; Sang Hyeon Son; Bong-Suk Jin; Jung-Hyun Na; Soo-Youl Kim; Kook-Han Kim; Eunice Eunkyeong Kim; Yeon Gyu Yu; Hyung Ho Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

Review 10.  Protein kinase CK2 in health and disease: CK2: a key player in cancer biology.

Authors:  J H Trembley; G Wang; G Unger; J Slaton; K Ahmed
Journal:  Cell Mol Life Sci       Date:  2009-06       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.